Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorothiazinone for Prophylaxis of Nosocomial Infections in MV Patients
NCT06135350Phase 2Recruiting
- Start
- Nov 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fluorothiazinone in ventilator-associated pneumonia (VAP). Started Nov 2023; status: recruiting.
02
Drugs
Fluorothiazinone
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT06135350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06135350.